Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes

International Journal of Ophthalmology

Volumn 5, Issue 4, 2012, Pages 499-504

  Jew, Ong Ming ^a   Peyman, Mohammadreza ^a   Chen, Tan Chen ^a   Visvaraja, Subrayan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Clinically significant macular edema; Diabetes; Risk factors

Indexed keywords

EID: 84888279196     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2012.04.18     Document Type: Article

References (27)

1. Klein R, Klein BE, Moss S.E., Davis MD, DeMets DL The wisconsin epidemiologic study of diabetic retinopathy ii: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
2. Williams R, Airey M, Baxter H., Forrester J, Kennedy-Martin, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye(lond) 2004;18(10):963-983.
3. Sharma A, Kuppermann BD New and in-development treatments for diabetic macular edema. Retinal Physician. 2008. http://www.retinalphysician.com/ articleviewer.aspx?articleid=101898.
4. Singh A, Stewart JM Pathophysiology of diabetic macular edema. Int Ophthalmol Clin. 2009;49(2):1-11.
5. Simmons EP, Foster CS Diabetic retinopathy and macular edema. Contemp Ophthalmol. 2007;6(8):1-8.
6. Zander E, Herfurth S, Bohl B., Heinke P, Herrmann U, Kohnert KD Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol. 2000;84(8):871-876.
7. Su DH, Yeo KT Diabetic retinopathy and serum lipids. Singapore Med J. 2000;41(6):295-297.
8. Chew EY, Klein ML, Ferris FL Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthal. 1996;114(9):1079-1084.
9. Klein BEK, Moss SE, Klein R, Surawicz TS The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98(8):1261-1265.
10. Klein BK, Klein R, Moss SE Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration? Am J Ophthalmol. 1999;128(5):652-654.
11. Ozer PA, Unlu N, Demir M.N., Hazirolan DO, Acar MA, Duman S. Serum lipid profile in diabetic macular edema. J Diabetes Complications. 2009;23(4):244-248.
12. Asensio-Sánchez VM, Gómez-Ramírez V, Morales-Gómez I, Rodríguez-Vaca I. Clinically significant diabetic macular oedema: systemic risk factors. Arch Soc Esp Oftalmol. 2008;83(3):173-176.
13. rd National Health and Morbidity Survey (NHMS III) Diabetes Res Clin Pract. 2008;79(1):S1-S127.
14. Tajunisah I, Nabilah H, Reddy SC Prevalence and risk factors of diabetic retinopathy: a study of 217 patients from University Malaya Medical Center. Med J Malaya. 2006;61(4):451-456.
15. Miljanovic B, Glynn RJ, Nathan D.M., Manson J E, Schaumberg D A. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883-2892.
16. Ucgun NI, Yildirim Z, Kilic N., Gursel E. The importance of serum lipids in exudative diabetic macular edema in type 2 diabetic patients. Ann N YAcad Sci. 2007;1100:213-217.
17. Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost. 2000;26(5):529-537.
18. Awata T, Neda T, Iizuka H., Kirihara S, Ohkubo T, Takata N. Endothelial nitric oxide synthase gene is associated with diabetic macular oedema in type 2 diabetes. Diabetes Care. 2004;27(9):2184-2190.
19. Galler A, Muller G, Schinzel R., Kratzsch J, Kiess W, Munch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and N-(carboxymethyl)lysine ELISA. Diabetes Care. 2003;26(9):2609-2615.
20. Knudsen L.L., Lervang HH, Lundbye-Christensen S, Gorst-Rasmussen A. The North Jutland County Diabetic Retinopathy Study (NCDRS). Non-ophthalmic parameters and clinically significant macular oedema. Br J Ophthalmol. 2007;91(12):1593-1595.
21. Monique S.R., Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus. Arch Ophthal. 2006;124(9):1297-1306.
22. Khan H.A., Sobki SH, Khan SA Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clin Exp Med. 2007;7(1):24-29.
23. Khan HA. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol. 2007;44(4):193-200.
24. Klein R, Klein BE, Moss S.E., Davis MD, DeMets DL The Wisconsin epidemiologic study of diabetic retinopathy III: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthal. 1984;102(4):527-532.
25. McGill J.B., Bell D S H. Anemia and the role of erythropoietin in diabetes. J Diabetes Complications. 2006;20(4):262-272.
26. Gardner TW, Antonetti DA, Barber A J, LaNoue KF, Levison S.W., The Penn State Retina Research Group Diabetic Retinopathy: More than meets the eye. Surv Ophthalmol. 2002;47(S2):S253-S262.
27. Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes. Arch Ophthal. 2001;119(2):251-259.